Immunotherapy of Cancer Conference (ITOC)

The ITOC is the leading international conference on immunotherapy of cancer in Europe, organized by CDDF in collaboration with SITC.

The goal of the Conference is to provide a forum for discussion of early clinical drug development and address the unique challenges of immuno-oncology, with a special emphasis on clinical trials, translational research and biomarker development.

ITOC attracts a multi-stakeholder attendance connecting preclinical and clinical scientists, clinicians, healthcare professionals, academia and other stakeholders who are involved in the development of novel anticancer agents.